Community Composition Determines Activity of Antibiotics against Multispecies Biofilms
- 1 September 2017
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 61 (9) , e00302-17
Abstract
In young cystic fibrosis (CF) patients, Staphylococcus aureus is typically the most prevalent organism, while in adults, Pseudomonas aeruginosa is the major pathogen. More recently, it was observed that also Streptococcus anginosus plays an important role in exacerbations of respiratory symptoms. These species are often coisolated from CF lungs, yet little is known about whether antibiotic killing of one species is influenced by the presence of others. In the present study, we compared the activities of various antibiotics against S. anginosus , S. aureus , and P. aeruginosa when grown in monospecies biofilms with the activity observed in a multispecies biofilm. Our results show that differences in antibiotic activity against species grown in mono- and multispecies biofilms are species and antibiotic dependent. Fewer S. anginosus cells are killed by antibiotics that interfere with cell wall synthesis (amoxicillin plus sulbactam, cefepime, imipenem, meropenem, and vancomycin) in the presence of S. aureus and P. aeruginosa , while for ciprofloxacin, levofloxacin, and tobramycin, no difference was observed. In addition, we observed that the cell-free supernatant of S. aureus , but not that of P. aeruginosa biofilms, also caused this decrease in killing. Overall, S. aureus was more affected by antibiotic treatment in a multispecies biofilm, while for P. aeruginosa , no differences were observed between growth in mono- or multispecies biofilms. The results of the present study suggest that it is important to take the community composition into account when evaluating the effect of antimicrobial treatments against certain species in mixed biofilms.Keywords
Funding Information
- Belspo - IUAP (P7/28)
- FWO-Vlaanderen (Odysseus II Grant)
This publication has 57 references indexed in Scilit:
- Tobramycin-Treated Pseudomonas aeruginosa PA14 Enhances Streptococcus constellatus 7155 Biofilm Formation in a Cystic Fibrosis Model SystemJournal of Bacteriology, 2016
- Lung microbiota across age and disease stage in cystic fibrosisScientific Reports, 2015
- Safety and Pharmacokinetics of Ciprofloxacin Dry Powder for Inhalation in Cystic Fibrosis: A Phase I, Randomized, Single-Dose, Dose-Escalation StudyJournal of Aerosol Medicine and Pulmonary Drug Delivery, 2014
- Impact of Staphylococcus aureus on Pathogenesis in Polymicrobial InfectionsInfection and Immunity, 2014
- Developing an international Pseudomonas aeruginosa reference panelMicrobiologyopen, 2013
- Differential Potentiation of the Virulence of the Pseudomonas aeruginosa Cystic Fibrosis Liverpool Epidemic Strain by Oral Commensal StreptococciThe Journal of Infectious Diseases, 2013
- Biofilm extracellular DNA enhances mixed species biofilms of Staphylococcus epidermidis and Candida albicansBMC Microbiology, 2013
- Prevalence of Streptococci and Increased Polymicrobial Diversity Associated with Cystic Fibrosis Patient StabilityJournal of Bacteriology, 2012
- Population structure and characterization of viridans group streptococci (VGS) including Streptococcus pneumoniae isolated from adult patients with cystic fibrosis (CF)Journal of Cystic Fibrosis, 2011
- The Streptococcus milleri group—An unrecognized cause of disease in cystic fibrosis: A case series and literature reviewPediatric Pulmonology, 2008